Biomarkers relative to NSCLC prediction and prognosis have been reported, such as the epidermal growth factor receptor (EGFR)-related biomarkers (EGFR, Ki-67, pAKT and p27) (2–9). The gene discussed is MKI67; the disease is non-small cell lung carcinoma.